4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0002043395-26-000012
Chief Medical Officer sold 12,000 shares at $12.18 ($146,160)
- Chief Medical Officer acquired 168 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sayad Pierre Sargis · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-31 | Grant or award : show line 1 in the form | +168 | 21,519 | D | ||
| 2026-08-31 | Sale : show line 2 in the form | −12,000 | $12.18 | $146,160 | 9,519 | D |
| Open-market sales · 12,000 sh · avg $12.18 · $146,160 | ||||||
Loading xslF345X06/form4-09012026_120920.xml…